Delivery Order SPE2DB20D1050-SPE2DB24FH67C
Award Date 5/13/24
Potential Completion Date 5/14/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,524.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,064,916 units of VYVANSE 30 MG CAPSULE 100S. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 5, 2024. Amerisourcebergen, through its Corporate Office division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the corporate office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of 4564828902 VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract has a ceiling value of $1,547.06 and an ultimate completion date of June 7, 2024. This is a firm fixed-price delivery order contract, without a set-aside designation....
- This contract award, valued at $3,905.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The award is a firm fixed price delivery order for the supply of 4564097876 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- This federal contract award, valued at $1,052.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 30 MG CAPSULES 100S, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 10, 2024. The contract was awarded on December 9, 2024 and was not designated with a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a delivery order valued at $1,724.00, is for the provision of 4564214559 VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 9, 2024. This award is not associated...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
- This federal contract award, valued at $1,724.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565592570 VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. It is a firm fixed-price delivery order contract with an ultimate completion date of August 27, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical...
- This federal contract award, valued at $14,167.87, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,069,076 units of the pharmaceutical product VYVANSE 60 MG CAPSULE 100S. The contract is a firm fixed price delivery order with a completion date of March 7, 2024. No set-aside designation was used for this...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,783.60, is a Firm Fixed Price Delivery Order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen is the prime contractor and there is no indication of any set-aside designation for this...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,049.90 to provide VYVANSE 30 MG CAPSULE 100S. This contract does not have a set-aside designation and is scheduled for completion on March 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and is responsible for delivering the pharmaceutical product to support military treatment...